Does RIBOCICLIB Cause Dyspnoea at rest? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Dyspnoea at rest have been filed in association with RIBOCICLIB (KISQALI). This represents 0.1% of all adverse event reports for RIBOCICLIB.
18
Reports of Dyspnoea at rest with RIBOCICLIB
0.1%
of all RIBOCICLIB reports
6
Deaths
13
Hospitalizations
How Dangerous Is Dyspnoea at rest From RIBOCICLIB?
Of the 18 reports, 6 (33.3%) resulted in death, 13 (72.2%) required hospitalization.
Is Dyspnoea at rest Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOCICLIB. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOCICLIB Cause?
Neutropenia (3,585)
Nausea (3,404)
Fatigue (3,327)
Malignant neoplasm progression (2,468)
Death (2,452)
Vomiting (1,953)
Diarrhoea (1,830)
White blood cell count decreased (1,683)
Pain (1,637)
Metastases to bone (1,538)
What Other Drugs Cause Dyspnoea at rest?
TREPROSTINIL (314)
OMALIZUMAB (145)
MACITENTAN (140)
BISOPROLOL (136)
AMBRISENTAN (124)
ASPIRIN (108)
RAMIPRIL (101)
PANTOPRAZOLE (98)
AMLODIPINE (96)
ATORVASTATIN (92)
Which RIBOCICLIB Alternatives Have Lower Dyspnoea at rest Risk?
RIBOCICLIB vs RIBOFLAVIN
RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE
RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE
RIBOCICLIB vs RIFABUTIN
RIBOCICLIB vs RIFAMPICIN